Trials show vaccine is safe


Posted on July 1st, by editor in Caring Times. No Comments

Initial results of a clinical trial of a potential vaccine for Alzheimer1s Disease have shown that it is safe and well-tolerated in humans. The World Alzheimer Congress 2000, held in Washington DC in July, heard that animal studies of the vaccine, AN-1792, confirmed that it leads to an immune response which increases the clearance of amyloid plaques from the brain and prevents additional plaques from forming. (Scientists believe that amyloid plaques, found in the brains of most individuals with AD, impede nerve cell function and cause cell death.) The researcher is Dale Schenk from Elan Pharmaceuticals, who said: “Amyloid plaques act as a brain invader. We are optimistic that we can attack this invader at its source and eventually help millions of people and families world wide.”





Comments are closed.


Latest blog posts

Inconstant gardeners

By Caring Times editor GEOFF HODGSON

Last Saturday was fine and dry so I managed to put in a few hours on our allotment. Not...

When the chips go down . . .

By Caring Times editor GEOFF HODGSON

I have heard people say they couldn’t get by without their smartphone, and I suppose this must be true...

Loneliness behind the front doors

By Guest Blogger KEITH LEWIN

Last week SCIE issued its monthly ‘Briefing for Commissioners’, its focus is on social isolation which it correctly says “can...